Back to Search
Start Over
High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial
- Source :
- The Lancet Respiratory Medicine; 20240101, Issue: Preprints
- Publication Year :
- 2024
-
Abstract
- Convalescent plasma has been proposed as an early treatment to interrupt the progression of early COVID-19 to severe disease, but there is little definitive evidence. We aimed to assess whether early treatment with convalescent plasma reduces the risk of hospitalisation and reduces SARS-CoV-2 viral load among outpatients with COVID-19.
Details
- Language :
- English
- ISSN :
- 22132600 and 22132619
- Issue :
- Preprints
- Database :
- Supplemental Index
- Journal :
- The Lancet Respiratory Medicine
- Publication Type :
- Periodical
- Accession number :
- ejs58892996
- Full Text :
- https://doi.org/10.1016/S2213-2600(21)00545-2